CN Patent
CN100562514C — 一类取代丙酰胺衍生物、其制备方法和用途
Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2009-11-25 · 16y expired
What this patent protects
本发明提供以下通式所述的一类化合物:以及该类化合物的制备方法和作为一类新型过氧化物酶体增殖子活化受体γ激动剂在糖尿病及其并发症药物治疗中的应用。
USPTO Abstract
本发明提供以下通式所述的一类化合物:以及该类化合物的制备方法和作为一类新型过氧化物酶体增殖子活化受体γ激动剂在糖尿病及其并发症药物治疗中的应用。
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.